MiNK Therapeutics(INKT) - 2021 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | Delaware | 82-2142067 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 149 Fifth Avenue | | | Suite 500 | | | New York, NY | 10010 | | (Address of principal executive offices) | (Zip Code) | | Registrant's telephone number, including area code: 212- ...